- Home
- ORGO vs GOOD Comparison
ORGO vs GOOD Comparison
Compare ORGO & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- GOOD
- Stock Information
- Founded
- ORGO 1985
- GOOD 2003
- Country
- ORGO United States
- GOOD United States
- Employees
- ORGO N/A
- GOOD N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- GOOD Real Estate Investment Trusts
- Sector
- ORGO Health Care
- GOOD Real Estate
- Exchange
- ORGO Nasdaq
- GOOD Nasdaq
- Market Cap
- ORGO 533.9M
- GOOD 614.5M
- IPO Year
- ORGO N/A
- GOOD N/A
- Fundamental
- Price
- ORGO $5.34
- GOOD $13.88
- Analyst Decision
- ORGO Buy
- GOOD Hold
- Analyst Count
- ORGO 2
- GOOD 1
- Target Price
- ORGO $5.50
- GOOD $15.00
- AVG Volume (30 Days)
- ORGO 1.7M
- GOOD 314.1K
- Earning Date
- ORGO 05-08-2025
- GOOD 05-07-2025
- Dividend Yield
- ORGO N/A
- GOOD 8.71%
- EPS Growth
- ORGO N/A
- GOOD N/A
- EPS
- ORGO N/A
- GOOD 0.30
- Revenue
- ORGO $482,043,000.00
- GOOD $151,168,000.00
- Revenue This Year
- ORGO $3.31
- GOOD $3.44
- Revenue Next Year
- ORGO $12.50
- GOOD $2.60
- P/E Ratio
- ORGO N/A
- GOOD $46.71
- Revenue Growth
- ORGO 11.29
- GOOD 3.01
- 52 Week Low
- ORGO $2.17
- GOOD $12.67
- 52 Week High
- ORGO $6.71
- GOOD $17.88
- Technical
- Relative Strength Index (RSI)
- ORGO 67.16
- GOOD 37.24
- Support Level
- ORGO $5.14
- GOOD $13.88
- Resistance Level
- ORGO $5.42
- GOOD $14.18
- Average True Range (ATR)
- ORGO 0.28
- GOOD 0.27
- MACD
- ORGO 0.09
- GOOD 0.02
- Stochastic Oscillator
- ORGO 85.09
- GOOD 27.08
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.